EP1210923B1 - Control system for corneal laser surgery - Google Patents

Control system for corneal laser surgery Download PDF

Info

Publication number
EP1210923B1
EP1210923B1 EP01308220A EP01308220A EP1210923B1 EP 1210923 B1 EP1210923 B1 EP 1210923B1 EP 01308220 A EP01308220 A EP 01308220A EP 01308220 A EP01308220 A EP 01308220A EP 1210923 B1 EP1210923 B1 EP 1210923B1
Authority
EP
European Patent Office
Prior art keywords
wavefront
exposed
laser beam
stromal
error signal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP01308220A
Other languages
German (de)
French (fr)
Other versions
EP1210923A2 (en
EP1210923A3 (en
Inventor
Josef Bille
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
20 10 Perfect Vision GmbH
Original Assignee
20 10 Perfect Vision Optische Geraete GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 20 10 Perfect Vision Optische Geraete GmbH filed Critical 20 10 Perfect Vision Optische Geraete GmbH
Publication of EP1210923A2 publication Critical patent/EP1210923A2/en
Publication of EP1210923A3 publication Critical patent/EP1210923A3/en
Application granted granted Critical
Publication of EP1210923B1 publication Critical patent/EP1210923B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/1015—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for wavefront analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F9/00802—Methods or devices for eye surgery using laser for photoablation
    • A61F9/00804—Refractive treatments
    • A61F9/00806—Correction of higher orders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00017—Electrical control of surgical instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00844—Feedback systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00844—Feedback systems
    • A61F2009/00848—Feedback systems based on wavefront
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00855—Calibration of the laser system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/00872—Cornea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00878—Planning
    • A61F2009/0088—Planning based on wavefront

Definitions

  • the present invention pertains generally to the control of a laser beam. More particularly, the present invention pertains to systems for controlling a laser beam by using an active mirror in accordance with wavefront analysis techniques. The present invention is particularly, but not exclusively, useful as a system for controlling a laser beam in ophthalmic applications wherein mechanically introduced optical aberrations require compensation.
  • an excimer laser has a relatively large spot size (e.g. approximately one millimeter in diameter). It is also known that an excimer laser will superficially photoablate an exposed layer of stromal tissue to a substantially uniform depth within the spot size. Consequently, any undulations of one millimeter that are initially present on an exposed surface of stromal tissue will persist and will still be present after the procedure has been completed. This, however, is good. Although the surface undulations will introduce aberrations during the procedure, these same aberrations will be cancelled when the flap is lowered onto the exposed surface.
  • US-A-5 949 521 discloses a method for preparing a system for photoablation of a mechanically exposed stromal surface of an eye.
  • the present invention provides a closed-loop control system for superficial photoablation of tissue from an exposed stromal surface of an eye wherein the exposed surface introduces mechanically induced optical aberrations, said system comprising a source for generating an incising laser beam for photoablation of tissue from the exposed surface, a source for generating a diagnostic laser beam, a deformable mirror for directing said diagnostic laser beam through the exposed stromal surface to a focal spot on the retina of the eye, a detector for using light from said diagnostic beam reflected from the retina through the exposed stromal surface to generate an induced wavefront having characteristics of the mechanically induced optical aberrations, together with a distorted wavefront having actual real-time characteristics of the comea, a compensator for altering a predetermined desired wavefront by incorporating said induced wavefront therewith to create a rectified wavefront, a comparator for comparing said rectified wavefront with said distorted wavefront to create an error signal, a means for reconfiguring said deformable mirror in accordance with said error signal to maintain
  • the present invention proviedes a closed-loop control system for use in a so-called LASIK "flap and zap" procedure.
  • this closed-loop control is accomplished using wavefront analysis, and it is provided to compensate for optical aberrations that can be mechanically induced during the procedure.
  • wavefront analysis it is important to appreciate that the patient will be examined and diagnosed prior to the corrective surgical procedure.
  • the naturally occurring optical aberrations of an eye, that are unwanted and therefore need to be corrected will be known and can serve as a starting point.
  • the naturally occurring optical aberrations of an eye can be characterized as a distorted wavefront.
  • tissue will be removed from the stroma and the distorted wavefront will change accordingly.
  • Deviations between the dynamically changing, distorted wavefront and a predetermined, desired wavefront e.g. a plane wavefront
  • a predetermined, desired wavefront e.g. a plane wavefront
  • the closed-loop control system of the present invention includes a source for generating an incising laser beam.
  • the incising laser beam is an excimer laser and will have a focal spot that is approximately one millimeter in diameter.
  • the incising laser beam is only used to photoablate tissue from the exposed stromal surface after the flap has been lifted.
  • the system of the present invention also includes an additional laser source for generating a diagnostic laser beam.
  • an additional laser source for generating a diagnostic laser beam.
  • a deformable mirror for directing this diagnostic laser beam through the exposed stromal surface toward a focal spot on the retina of the eye.
  • the deformable mirror that is used for the present invention is of a type disclosed in European Patent Application 00309707.8. Light in the diagnostic laser beam will then be reflected from the focal spot on the retina and directed back through the exposed stromal surface.
  • a detector is positioned to receive light of the diagnostic beam that is reflected from the retina, back through the exposed stromal surface.
  • light in the diagnostic beam that is reflected from the retina will include two identifiable components.
  • One component is a contribution that is characteristic of the distorted wavefront that was determined earlier during patient diagnosis.
  • the other component will be a contribution from the optical aberrations that are introduced during the cutting of the corneal flap.
  • both component contributions can be characterized by distinct wavefronts.
  • the component contribution that is introduced during the cutting of the corneal flap is hereinafter referred to as an induced wavefront.
  • the distorted wavefront has been previously determined during diagnosis.
  • the actually detected wavefront will include both the distorted wavefront and the induced wavefront. Therefore, the induced wavefront, which will not change during the procedure, can be determined by removing the distorted wavefront from the actually detected wavefront.
  • the detector identifies and models, or generates, the induced wavefront that has characteristics of the mechanically induced optical aberrations. All of this is done using actual real-time characteristics of the cornea.
  • the system of the present invention also incorporates a compensator.
  • the compensator uses the induced wavefront to alter the desired wavefront. This is done by incorporating the induced wavefront with the desired wavefront, to create a rectified wavefront. In most applications, the desired wavefront will be a simple plane wavefront.
  • the system of the present invention is concerned with four specifically different wavefronts. These are: 1) a distorted wavefront that is characteristic of the uncorrected eye; 2) a desired wavefront for the corrected eye (this is the overall objective of the procedure); 3) an induced wavefront that is characteristic of the optical aberrations introduced during creation of the flap; and 4) a rectified wavefront that is a summation of 2) and 3).
  • the error signal represents the amount of correction required in the cornea (desired wavefront), and it includes a factor that compensates for the optical aberrations that were mechanically introduced during creation of the flap (induced wavefront). In effect, during the procedure the induced wavefront is preserved.
  • the error signal is actually used for two purposes.
  • the error signal is used to reconfigure the deformable mirror and to thereby maintain a focal spot on the retina. This is important in order for the system to continuously determine the distorted wavefront as it is being altered by the photoablation of stromal tissue.
  • the error signal is used to deactivate the incising laser when the error signal is a null to thereby indicate that the proper correction has been accomplished.
  • the flap is lowered onto the exposed, and now altered, stromal surface. Because the induced wavefront was preserved during the procedure, the undulations on the flap will mate with the preserved undulations on the exposed stromal surface. This will effectively cancel the optical aberrations that would otherwise be present.
  • a system for controlling the superficial photoablation of tissue from an exposed stromal surface of an eye is shown and generally designated 10.
  • the purpose of the system 10 is to control the photoablation of tissue from the eye 12. More specifically, the purpose of the system 10 is to control the photoablation of tissue from the surface 14 of stromal tissue that is exposed when a flap 16 of corneal tissue is lifted from the surface 14.
  • the flap 16 will be mechanically created using a sharp cutting instrument such as a keratome (not shown).
  • Fig. 2 An overview of the system 10 from the perspective of wavefront analysis techniques is perhaps best appreciated with reference to Fig. 2.
  • Fig. 2 it will be seen that initially a distorted wavefront 18 is received by a detector 20.
  • the distorted wavefront 18 may come from any source. In the context of the present invention, however, the distorted wavefront 18 is received from the eye 12. This distorted wavefront 18 is then processed and analyzed by the detector 20.
  • the detector 20 preferably includes a Hartmann-Shack type sensor which is capable of generating data that will be representative of the distorted wavefront 18.
  • the distorted wavefront 18 that is received from the eye 12 will include two components of information. One component is caused by the naturally occurring optical aberrations in the eye 12 that are to be corrected. The other component includes the optical aberrations that were mechanically induced when the flap 16 was being created by a cutting instrument (e.g. keratome).
  • the detector 20 determines an induced wavefront 22 that is representative of the optical aberrations induced by cutting the flap 16.
  • the induced wavefront 22 is characterized by useable data.
  • the data for the induced wavefront 22 is transferred to a compensator 24.
  • the induced wavefront 22 is incorporated with a desired wavefront 26 to create a rectified wavefront 28.
  • the desired wavefront 26 will have the optical characteristics that are desired for the eye 12 after the procedure has been completed.
  • the desired wavefront 26 will, in most instances, be a plane wavefront.
  • a comparator 30 is used for the system 10 to determine the differences that exist between the distorted wavefront 18 and the rectified wavefront 28.
  • the function of the comparator 30 is, essentially, to generate an error signal 32.
  • the error signal 32 is used to program an active mirror 34.
  • the error signal 32 is used to control the operation of an incising laser source 36.
  • the incising laser source 36 will be an excimer laser. The interaction of these functions will be best appreciated by referring back to Fig. 1.
  • the system 10 includes a diagnostic laser source 38 which is used to generate a diagnostic laser beam 40. As shown, this diagnostic laser beam 40 is directed toward the active mirror 34 for reflection therefrom. As indicated above, the active mirror 34 used in the system 10 is preferably of a type disclosed in European Patent Application 00309707.8. After being reflected from the active mirror 34, the diagnostic laser beam 40 passes through a beam splitter 42 and a beam splitter 44 enroute to the eye 12.
  • the diagnostic laser beam 40 is focused to a focal spot 46 on the retina 48 of the eye 12.
  • the reflected diagnostic laser beam 40' then passes out of the eye 12 through the exposed stromal surface 14 and is directed by the beam splitter 44 (which is acting like a turning mirror) toward the detector 20.
  • the diagnostic laser beam 40' is characterized by the distorted wavefront 18.
  • the detector 20 is then used to extract the induced wavefront 22 from the distorted wavefront 18.
  • the induced wavefront 22 is then sent to the compensator 24 and the distorted wavefront 18 is sent to the comparator 30.
  • the rectified wavefront 28 i.e. a combination of desired wavefront 26 and induced wavefront 22
  • Fig. 1 shows that the error signal 32 is sent both to the active mirror 34 and to the incising laser source 36 (e.g. an excimer laser).
  • the incising laser source 36 is activated by the error signal 32 to generate an incising laser beam 50 which will be used to photoablate tissue from the exposed stmmal surface 14 of the eye 12.
  • the incising laser beam will be directed by the beam splitter 42 (acting like a turning mirror) toward the surface 14 of the eye 12.
  • the beam splitter 42 acting like a turning mirror
  • the error signal 32 can maintain the focal spot 46 on the retina 48 by propeny programming the active mirror 34. Accordingly, the incising laser source 36 will remain activated until the error signal 32 Is a null. When the error signal 32 is a null, the corrective procedure has been completed and the entire system 10 can be shut down.
  • a system of the present invention may be used in a method for controlling the superficial photoablation of tissue from an exposed stromal surface of an eye wherein the exposed surface introduces mechanically induced optical aberrations, said method comprising the steps of:
  • a system of the present invention can be used to control the superficial photoablation of tissue from an exposed stromal surface of an eye by:

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Laser Surgery Devices (AREA)
  • Eye Examination Apparatus (AREA)
  • Radiation-Therapy Devices (AREA)

Description

    FIELD OF THE INVENTION
  • The present invention pertains generally to the control of a laser beam. More particularly, the present invention pertains to systems for controlling a laser beam by using an active mirror in accordance with wavefront analysis techniques. The present invention is particularly, but not exclusively, useful as a system for controlling a laser beam in ophthalmic applications wherein mechanically introduced optical aberrations require compensation.
  • BACKGROUND OF THE INVENTION
  • In preparation for a so-called "flap and zap" (Lasik) ophthalmic laser surgery procedure, it is common practice to first create a stromal flap. Typically, this is done by mechanically cutting into the stroma to create the flap. To date, it has been the practice to accept the resultant incision as being substantially flat. Actually, however, the Interface surface that results when the flap is created is not flat. Instead, due to irregularities in the sharpness of the cutting blade, due to imperfect aplanation for stabilizing the cornea during cutting of the flap, and due to the resistance between the stromal tissue and the cutting blade as the flap is created, the resulting incision typically includes several surface irregularities. These irregularities, unfortunately, are significant. Indeed, it happens that these irregularities are generally in the form of asymmetric undulations that may vary in amplitude by as much as ten microns, and extend over a distance of as much as a millimeter. As is well known, undulations (surface irregularities) of this magnitude will induce noticeable aberrations in any wavefront that passes through the surface.
  • It is known that an excimer laser has a relatively large spot size (e.g. approximately one millimeter in diameter). It is also known that an excimer laser will superficially photoablate an exposed layer of stromal tissue to a substantially uniform depth within the spot size. Consequently, any undulations of one millimeter that are initially present on an exposed surface of stromal tissue will persist and will still be present after the procedure has been completed. This, however, is good. Although the surface undulations will introduce aberrations during the procedure, these same aberrations will be cancelled when the flap is lowered onto the exposed surface.
  • Heretofore, whenever closed-loop control of an excimer laser has been employed during ophthalmic surgery, the contribution of the surface irregularities (undulations) to the total aberrations of the eye has been generally disregarded. Consequently, it has been the practice in earlier closed-loop control systems to generate a controlling error signal by comparing the extent of actual tissue photoablation to the predetermined amount of desired photoablation. Using wavefront analysis, this has been done by identifying the actual distorted wavefront that is created by the stromal tissue (including the undulation contribution), and then comparing the distorted wavefront with a desired wavefront to generate the error signal. The desired wavefront, however, is normally determined off-site and is the result of a diagnostic examination. Thus, it is predetermined, and does not account for aberrations that are subsequently introduced by surface undulations (irregularities) when the flap is subsequently created at the time the procedure is to be performed. The result here is that the undulations on the exposed surface are removed along with the desired tissue removal.
  • US-A-5 949 521 discloses a method for preparing a system for photoablation of a mechanically exposed stromal surface of an eye.
  • In light of the above, it is an object of the present invention to provide a system for superficial photoablation of stromal tissue which compensates for the induced aberrations that are introduced when a flap of the cornea is mechanically created. It is another object of the present invention to provide a system for superficial photoablation of stromal tissue which generates an error signal that allows for more precise closed-loop control of photoablation during a procedure. Yet another object of the present invention is to provide a system for superficial photoablation of stromal tissue which is relatively easy to use, is simple to implement and is comparatively cost effective.
  • SUMMARY OF THE PREFERRED EMBODIMENTS
  • The present invention provides a closed-loop control system for superficial photoablation of tissue from an exposed stromal surface of an eye wherein the exposed surface introduces mechanically induced optical aberrations, said system comprising a source for generating an incising laser beam for photoablation of tissue from the exposed surface, a source for generating a diagnostic laser beam, a deformable mirror for directing said diagnostic laser beam through the exposed stromal surface to a focal spot on the retina of the eye, a detector for using light from said diagnostic beam reflected from the retina through the exposed stromal surface to generate an induced wavefront having characteristics of the mechanically induced optical aberrations, together with a distorted wavefront having actual real-time characteristics of the comea, a compensator for altering a predetermined desired wavefront by incorporating said induced wavefront therewith to create a rectified wavefront, a comparator for comparing said rectified wavefront with said distorted wavefront to create an error signal, a means for reconfiguring said deformable mirror in accordance with said error signal to maintain a focal spot on the retina; and a means for ceasing generation of said incising laser beam when said error signal is a null.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The novel features of this invention, as well as the invention itself, both as to its structure and its operation, will be best understood from the accompanying drawings, taken in conjunction with the accompanying description, in which similar reference characters refer to similar parts, and in which:
    • Fig. 1 is a schematic layout showing the interrelationships of components in a system for controlling the superficial photoablation of tissue from an exposed stromal surface of an eye in accordance with the present invention; and
    • Fig. 2 is a functional representation of the wavefront analysis techniques used in the operation of the system of the present invention.
    DESCRIPTION OF THE PREFERRED EMBODIMENT
  • Thus the present invention proviedes a closed-loop control system is provided for use in a so-called LASIK "flap and zap" procedure. Specifically, this closed-loop control is accomplished using wavefront analysis, and it is provided to compensate for optical aberrations that can be mechanically induced during the procedure. In the context of the present invention, it is important to appreciate that the patient will be examined and diagnosed prior to the corrective surgical procedure. Thus, the naturally occurring optical aberrations of an eye, that are unwanted and therefore need to be corrected, will be known and can serve as a starting point.
  • Importantly, the naturally occurring optical aberrations of an eye can be characterized as a distorted wavefront. As a corrective procedure is conducted, however, tissue will be removed from the stroma and the distorted wavefront will change accordingly. Deviations between the dynamically changing, distorted wavefront and a predetermined, desired wavefront (e.g. a plane wavefront) will then indicate the extent of corrections that are still required by the procedure. As appreciated by the present invention, in addition to all of this, there is a need to compensate for mechanically introduced optical aberrations.
  • In detail, the closed-loop control system of the present invention includes a source for generating an incising laser beam. Preferably, the incising laser beam is an excimer laser and will have a focal spot that is approximately one millimeter in diameter. As intended for the present invention, and implied above, the incising laser beam is only used to photoablate tissue from the exposed stromal surface after the flap has been lifted.
  • In addition to the incising laser source, the system of the present invention also includes an additional laser source for generating a diagnostic laser beam. Further, there is a deformable mirror for directing this diagnostic laser beam through the exposed stromal surface toward a focal spot on the retina of the eye. Preferably, the deformable mirror that is used for the present invention is of a type disclosed in European Patent Application 00309707.8. Light in the diagnostic laser beam will then be reflected from the focal spot on the retina and directed back through the exposed stromal surface.
  • A detector is positioned to receive light of the diagnostic beam that is reflected from the retina, back through the exposed stromal surface. At this point, it is to be appreciated that light in the diagnostic beam that is reflected from the retina will include two identifiable components. One component is a contribution that is characteristic of the distorted wavefront that was determined earlier during patient diagnosis. The other component will be a contribution from the optical aberrations that are introduced during the cutting of the corneal flap. Importantly, both component contributions can be characterized by distinct wavefronts.
  • For purposes of the present invention, the component contribution that is introduced during the cutting of the corneal flap is hereinafter referred to as an induced wavefront. On the other hand, the distorted wavefront has been previously determined during diagnosis. Further, as indicated above, after cutting the flap, but before any photoablation has been accomplished, the actually detected wavefront will include both the distorted wavefront and the induced wavefront. Therefore, the induced wavefront, which will not change during the procedure, can be determined by removing the distorted wavefront from the actually detected wavefront. Thus, the detector identifies and models, or generates, the induced wavefront that has characteristics of the mechanically induced optical aberrations. All of this is done using actual real-time characteristics of the cornea.
  • The system of the present invention also incorporates a compensator. Specifically, the compensator uses the induced wavefront to alter the desired wavefront. This is done by incorporating the induced wavefront with the desired wavefront, to create a rectified wavefront. In most applications, the desired wavefront will be a simple plane wavefront.
  • At this point it is helpful to recall that the system of the present invention is concerned with four specifically different wavefronts. These are: 1) a distorted wavefront that is characteristic of the uncorrected eye; 2) a desired wavefront for the corrected eye (this is the overall objective of the procedure); 3) an induced wavefront that is characteristic of the optical aberrations introduced during creation of the flap; and 4) a rectified wavefront that is a summation of 2) and 3).
  • In accordance with well known techniques for establishing closed-loop control, it is necessary to create an error signal. For the present invention, this function is accomplished by a comparator that compares the rectified wavefront (i.e. the desired wavefront incorporating the induced wavefront) with the distorted wavefront. Stated differently, the error signal represents the amount of correction required in the cornea (desired wavefront), and it includes a factor that compensates for the optical aberrations that were mechanically introduced during creation of the flap (induced wavefront). In effect, during the procedure the induced wavefront is preserved.
  • For the system of the present invention, the error signal is actually used for two purposes. For one, the error signal is used to reconfigure the deformable mirror and to thereby maintain a focal spot on the retina. This is important in order for the system to continuously determine the distorted wavefront as it is being altered by the photoablation of stromal tissue. For another, the error signal is used to deactivate the incising laser when the error signal is a null to thereby indicate that the proper correction has been accomplished.
  • Once the procedure has been completed, the flap is lowered onto the exposed, and now altered, stromal surface. Because the induced wavefront was preserved during the procedure, the undulations on the flap will mate with the preserved undulations on the exposed stromal surface. This will effectively cancel the optical aberrations that would otherwise be present.
  • Referring initially to Fig. 1 a system for controlling the superficial photoablation of tissue from an exposed stromal surface of an eye is shown and generally designated 10. In accordance with the present invention, the purpose of the system 10 is to control the photoablation of tissue from the eye 12. More specifically, the purpose of the system 10 is to control the photoablation of tissue from the surface 14 of stromal tissue that is exposed when a flap 16 of corneal tissue is lifted from the surface 14. As contemplated for the present invention, the flap 16 will be mechanically created using a sharp cutting instrument such as a keratome (not shown).
  • An overview of the system 10 from the perspective of wavefront analysis techniques is perhaps best appreciated with reference to Fig. 2. In Fig. 2 it will be seen that initially a distorted wavefront 18 is received by a detector 20. As a general proposition it will be understood that the distorted wavefront 18 may come from any source. In the context of the present invention, however, the distorted wavefront 18 is received from the eye 12. This distorted wavefront 18 is then processed and analyzed by the detector 20.
  • For the system 10, the detector 20 preferably includes a Hartmann-Shack type sensor which is capable of generating data that will be representative of the distorted wavefront 18. As contemplated for the system 10, the distorted wavefront 18 that is received from the eye 12 will include two components of information. One component is caused by the naturally occurring optical aberrations in the eye 12 that are to be corrected. The other component includes the optical aberrations that were mechanically induced when the flap 16 was being created by a cutting instrument (e.g. keratome). Using predetermined diagnostic information about the corrections to the eye 12 that are to be made by the system 10, the detector 20 determines an induced wavefront 22 that is representative of the optical aberrations induced by cutting the flap 16. Like the distorted wavefront 18, the induced wavefront 22 is characterized by useable data.
  • Once an induced wavefront 22 has been determined by the detector 20, the data for the induced wavefront 22 is transferred to a compensator 24. At the compensator 24 the induced wavefront 22 is incorporated with a desired wavefront 26 to create a rectified wavefront 28. As a general notion, the desired wavefront 26 will have the optical characteristics that are desired for the eye 12 after the procedure has been completed. Thus, the desired wavefront 26 will, in most instances, be a plane wavefront.
  • A comparator 30 is used for the system 10 to determine the differences that exist between the distorted wavefront 18 and the rectified wavefront 28. Thus, the function of the comparator 30 is, essentially, to generate an error signal 32. As indicated in Fig. 2, the use of the error signal 32 is at least twofold. For one, the error signal 32 is used to program an active mirror 34. For another, the error signal 32 is used to control the operation of an incising laser source 36. As contemplated by the present invention, the incising laser source 36 will be an excimer laser. The interaction of these functions will be best appreciated by referring back to Fig. 1.
  • In Fig. 1 it will be seen that the system 10 includes a diagnostic laser source 38 which is used to generate a diagnostic laser beam 40. As shown, this diagnostic laser beam 40 is directed toward the active mirror 34 for reflection therefrom. As indicated above, the active mirror 34 used in the system 10 is preferably of a type disclosed in European Patent Application 00309707.8. After being reflected from the active mirror 34, the diagnostic laser beam 40 passes through a beam splitter 42 and a beam splitter 44 enroute to the eye 12.
  • Using appropriate optical elements (not shown) the diagnostic laser beam 40 is focused to a focal spot 46 on the retina 48 of the eye 12. The reflected diagnostic laser beam 40' then passes out of the eye 12 through the exposed stromal surface 14 and is directed by the beam splitter 44 (which is acting like a turning mirror) toward the detector 20. In line with the above disclosure, the diagnostic laser beam 40' is characterized by the distorted wavefront 18. As indicated above, the detector 20 is then used to extract the induced wavefront 22 from the distorted wavefront 18. The induced wavefront 22 is then sent to the compensator 24 and the distorted wavefront 18 is sent to the comparator 30. The rectified wavefront 28 (i.e. a combination of desired wavefront 26 and induced wavefront 22) is then compared with the distorted wavefront 18 by the comparator 30 to generate the error signal 32.
  • Fig. 1 shows that the error signal 32 is sent both to the active mirror 34 and to the incising laser source 36 (e.g. an excimer laser). As intended for the system 10 of the present invention, the incising laser source 36 is activated by the error signal 32 to generate an incising laser beam 50 which will be used to photoablate tissue from the exposed stmmal surface 14 of the eye 12. Specifically, as shown, the incising laser beam will be directed by the beam splitter 42 (acting like a turning mirror) toward the surface 14 of the eye 12. As tissue is photoablated from the surface 14, the optical characteristics of the eye 12 will be changed. Consequently, the distorted wavefront 18 of the reflected diagnostic beam 40' and the focal spot 46 on the retina 48 will also be changed. The error signal 32, however, can maintain the focal spot 46 on the retina 48 by propeny programming the active mirror 34. Accordingly, the incising laser source 36 will remain activated until the error signal 32 Is a null. When the error signal 32 is a null, the corrective procedure has been completed and the entire system 10 can be shut down.
  • The skilled person will appreciate that a system of the present invention may be used in a method for controlling the superficial photoablation of tissue from an exposed stromal surface of an eye wherein the exposed surface introduces mechanically induced optical aberrations, said method comprising the steps of:
    • providing a predetermined a desired wavefront for the eye;
    • generating a diagnostic laser beam;
    • using said diagnostic laser beam to identify an induced wavefront, said induced wavefront being characteristic of the mechanically induced optical aberrations;
    • altering said desired wavefront with said induced wavefront to create a rectified wavefront;
    • generating an incising laser beam to photoablate tissue from the exposed surface;
    • using a deformable mirror to direct said diagnostic laser beam through the exposed stromal surface to a focal spot on the retina of the eye;
    • detecting a distorted wavefront with light from said diagnostic beam reflected from the retina through the exposed stromal surface, said distorted wavefront having actual real-time characteristics of the cornea;
    • comparing said rectified wavefront with said distorted wavefront to create an error signal;
    • reconfiguring said deformable mirror in accordance with said error signal to maintain a focal spot on the retina; and
    • ceasing generation of said incising laser beam when said error signal is a null. In one embodiment, said incising laser beam is an excimer laser.
    Preferably, said step for identifying the induced wavefront is performed using is a Hartmann-Shack sensor unit. Typically this method is used for the superficial photoablation of tissue from an exposed stromal surface of an eye wherein the stromal surface is exposed using a blade to create a stromal flap, the stromal flap being movable to expose the surface for photoablation of tissue. Usually, the desired wavefront is a plane wavefront.
  • Hence, a system of the present invention can be used to control the superficial photoablation of tissue from an exposed stromal surface of an eye by:
    • detecting a distorted wavefront in the light of a diagnostic laser beam after reflection of said diagnostic laser beam from a focal spot on the retina of the eye;
    • extracting an induced wavefront from said distorted wavefront;
    • adding said induced wavefront to a desired wavefront to obtain a rectified wavefront;
    • comparing said rectified wavefront with said distorted wavefront to generate an error signal;
    • employing said error signal to control said focal spot of said diagnostic beam on the retina for subsequent reuse in said detecting step; and
    • monitoring said error signal as said distorted wavefront changes during photoablation of exposed stromal tissue to cease photoablation thereof when said error signal is at a null. Typically, said distorted wavefront includes optical characteristics of the uncorrected eye. Usually, said desired wavefront is a plane wavefront. Thus a system of the present invention is useful when the exposed surface introduces mechanically induced optical aberrations and said induced wavefront is characteristic of the mechanically induced optical aberrations. Accordingly, the system of the present invention may be used by using a deformable mirror to direct said diagnostic laser beam through the exposed stromal surface to said focal spot on the retina of the eye; and reconfiguring said deformable mirror in accordance with said error signal to maintain said focal spot on the retina. Preferably said photoablation is accomplished using an excimer laser, and typically the said extracting step is accomplished using a Hartmann-Shack sensor unit. Such a use is particularly applicable for circumstances wherein the stromal surface is exposed using a blade, typically a microkeratome, to create a stromal flap, the stromal flap being movable to expose the surface for photoablation of tissue.
  • While the particular Closed Loop Control for Refractive Laser Surgery (Lasik) as herein shown and disclosed in detail is fully capable of obtaining the objects and providing the advantages herein before stated, it is to be understood that it is merely illustrative of the presently preferred embodiments of the invention and that no limitations are intended to the details of construction or design herein shown other than as described in the appended claims.

Claims (5)

  1. A closed-loop control system (10) for superficial photoablation of tissue from an exposed stromal surface (14) of an eye (12) wherein the exposed surface (14) introduces mechanically induced optical aberrations, said system (10) comprising:
    a source (36) for generating an incising laser beam (50) for photoablation of tissue from the exposed surface (14);
    a source (38) for generating a diagnostic laser beam (40);
    a deformable mirror (34) for directing said diagnostic laser beam (40) through the exposed stromal surface (14) to a focal spot (46) on the retina (48) of the eye (12);
    a detector (20) for using light (40') from said diagnostic beam (40) reflected from the retina (48) through the exposed stromal surface (14) to generate an induced wavefront (22) having characteristics of the mechanically induced optical aberrations, together with a distorted wavefront (18) having actual real-time characteristics of the cornea;
    a compensator (24) for altering a predetermined desired wavefront (26) by incorporating said induced wavefront (22) therewith to create a rectified wavefront (28);
    a comparator (30) for comparing said rectified wavefront (28) with said distorted wavefront (18) to create an error signal (32);
    a means for reconfiguring said deformable mirror (34) in accordance with said error signal (32) to maintain a focal spot (46) on the retina (48); and
    a means for ceasing generation of said incising laser beam (50) when said error signal (32) is a null.
  2. A system (10) as recited in claim 1 wherein said source (36) for generating said incising laser beam (50) is an excimer laser.
  3. A system (10) as recited in claim 1 wherein said detector (20) for modeling the distorted wavefront (18) is a Hartmann-Shack sensor unit.
  4. A system (10) as recited in claim 1 wherein the stromal surface (14) has been exposed using a blade to create a stromal flap (16), the stromal flap (16) being movable to expose the surface (14) for photoablation of tissue.
  5. A system (10) as recited in claim 1 wherein the desired wavefront (26) is a plane wavefront.
EP01308220A 2000-10-17 2001-09-27 Control system for corneal laser surgery Expired - Lifetime EP1210923B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/690,774 US6428533B1 (en) 2000-10-17 2000-10-17 Closed loop control for refractive laser surgery (LASIK)
US690774 2000-10-17

Publications (3)

Publication Number Publication Date
EP1210923A2 EP1210923A2 (en) 2002-06-05
EP1210923A3 EP1210923A3 (en) 2003-08-27
EP1210923B1 true EP1210923B1 (en) 2006-03-29

Family

ID=24773901

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01308220A Expired - Lifetime EP1210923B1 (en) 2000-10-17 2001-09-27 Control system for corneal laser surgery

Country Status (5)

Country Link
US (1) US6428533B1 (en)
EP (1) EP1210923B1 (en)
JP (1) JP4086483B2 (en)
DE (1) DE60118311T2 (en)
ES (1) ES2259651T3 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101364B2 (en) * 2001-10-12 2006-09-05 20/10 Perfect Vision Optische Geraete Gmbh Method and apparatus for intrastromal refractive surgery
US6641577B2 (en) * 2001-11-28 2003-11-04 20/10 Perfect Vision Optische Geraete Gmbh Apparatus and method for creating a corneal flap
US20080287935A1 (en) * 2002-11-13 2008-11-20 Josef Bille System and method for photoablation using multiple focal points using cyclical phase modulation
US6887232B2 (en) * 2002-11-13 2005-05-03 20/10 Perfect Vision Optische Geraete Gmbh Closed loop control for intrastromal wavefront-guided ablation
US7717906B2 (en) * 2002-11-13 2010-05-18 Technolas Perfect Vision Gmbh System and method for photoablation using multiple focal points with rotating beam splitter
US7232436B2 (en) * 2002-11-13 2007-06-19 Josef Bille Closed loop control for intrastromal wavefront-guided ablation with fractionated treatment program
US6910770B2 (en) * 2003-02-10 2005-06-28 Visx, Incorporated Eye refractor with active mirror wavefront sensor
EP1615575B1 (en) * 2003-04-18 2014-11-05 AMO Manufacturing USA, LLC Systems and methods for correcting high order aberrations in laser refractive surgery
US7360893B2 (en) 2004-08-31 2008-04-22 20/10 Perfect Vision Optische Geraete Gmbh Systems and methods for shaping wavefronts in polychromatic light using phase shifting elements
ES2355507T3 (en) * 2005-03-18 2011-03-28 Wavelight Gmbh DEVICE FOR OPHTHALMOLOGICAL LASER SURGERY.
US20070027438A1 (en) * 2005-07-26 2007-02-01 Frieder Loesel System and method for compensating a corneal dissection
EP2455100A3 (en) * 2005-11-07 2012-11-07 The Rockefeller University Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof
WO2007071401A1 (en) * 2005-12-21 2007-06-28 Novartis Ag Adaptive optic ophthalmic design system
US8820929B2 (en) 2006-01-20 2014-09-02 Clarity Medical Systems, Inc. Real-time measurement/display/record/playback of wavefront data for use in vision correction procedures
EP1834615B1 (en) * 2006-03-15 2012-08-15 WaveLight GmbH Control program for ophthalmologic surgery
US20070244472A1 (en) * 2006-04-17 2007-10-18 Tobias Kuhn System and method for creating suture channels
WO2008083015A2 (en) * 2006-12-31 2008-07-10 Novartis Ag Method and system for determining power profile for an eye
US8020994B2 (en) * 2008-09-04 2011-09-20 Heidelberg Engineering Gmbh Custom phase plate
US7988295B2 (en) * 2008-10-28 2011-08-02 Heidelberg Engineering Gmbh Laser control with phase plate feedback
US9642518B2 (en) 2010-03-30 2017-05-09 Amo Development, Llc Random eye generation systems and methods
US8409178B2 (en) 2010-03-30 2013-04-02 Amo Development Llc. Systems and methods for evaluating treatment tables for refractive surgery
US10028862B2 (en) * 2012-12-06 2018-07-24 Amo Development, Llc Compensation systems and methods for flap induced aberrations
US10582847B2 (en) 2010-12-30 2020-03-10 Amo Wavefront Sciences, Llc Method and system for eye measurements and cataract surgery planning using vector function derived from prior surgeries
US10582846B2 (en) 2010-12-30 2020-03-10 Amo Wavefront Sciences, Llc Method and system for eye measurements and cataract surgery planning using vector function derived from prior surgeries
US10583039B2 (en) 2010-12-30 2020-03-10 Amo Wavefront Sciences, Llc Method and system for eye measurements and cataract surgery planning using vector function derived from prior surgeries
EP3213724B1 (en) 2010-12-30 2019-09-18 Amo Wavefront Sciences, LLC Improved treatment planning method and system for controlling laser refractive surgery
US9501621B2 (en) 2011-03-18 2016-11-22 Amo Development, Llc Treatment validation systems and methods
US9770362B2 (en) * 2014-12-23 2017-09-26 Novartis Ag Wavefront correction for ophthalmic surgical lasers
CN111631779A (en) * 2020-05-29 2020-09-08 北京天星博迈迪医疗器械有限公司 Medical planing system, control method, speed control chip and storage medium

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3245939C2 (en) 1982-12-11 1985-12-19 Fa. Carl Zeiss, 7920 Heidenheim Device for generating an image of the fundus
US4772115A (en) 1986-09-02 1988-09-20 Computed Anatomy Incorporated Illuminated ring keratometer device
US4887592A (en) 1987-06-02 1989-12-19 Hanspeter Loertscher Cornea laser-cutting apparatus
US4988348A (en) 1989-05-26 1991-01-29 Intelligent Surgical Lasers, Inc. Method for reshaping the cornea
US5062702A (en) 1990-03-16 1991-11-05 Intelligent Surgical Lasers, Inc. Device for mapping corneal topography
US5777719A (en) * 1996-12-23 1998-07-07 University Of Rochester Method and apparatus for improving vision and the resolution of retinal images
AU740673B2 (en) * 1997-11-21 2001-11-08 Autonomous Technologies Corporation Objective measurement and correction of optical systems using wavefront analysis
PT1105037E (en) * 1998-08-19 2002-11-29 Autonomous Technologies Corp APPARATUS AND METHOD FOR MEASURING VISION DEFECTS OF A HUMAN EYE
US6050687A (en) 1999-06-11 2000-04-18 20/10 Perfect Vision Optische Geraete Gmbh Method and apparatus for measurement of the refractive properties of the human eye

Also Published As

Publication number Publication date
US6428533B1 (en) 2002-08-06
JP4086483B2 (en) 2008-05-14
DE60118311D1 (en) 2006-05-18
ES2259651T3 (en) 2006-10-16
EP1210923A2 (en) 2002-06-05
JP2002172129A (en) 2002-06-18
EP1210923A3 (en) 2003-08-27
DE60118311T2 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
US6428533B1 (en) Closed loop control for refractive laser surgery (LASIK)
US9462943B2 (en) Apparatus, system and method for precision depth measurement
EP1009484B1 (en) Method for corneal laser surgery
JP4326701B2 (en) Photorefractive corneal surgical device for higher order visual acuity defects
US8182472B2 (en) Intrastromal refractive correction systems and methods
US7662149B2 (en) Customized corneal flap
JP4918547B2 (en) System and method for compensating corneal incision
US8496651B2 (en) System and method for refractive surgery with augmentation by intrastromal corrective procedure
CA2756985C (en) Device for the laser radiation treatment of an eye
US9050173B2 (en) Ophthalmologic surgical system
JP2015213777A (en) Methods and apparatus for improved post-operative ocular optical performance
CN109152659B (en) Ophthalmic surgical method
US11864979B2 (en) Post-treatment in refraction correction during eye surgery
US20090187172A1 (en) Method for harvesting corneal donor plugs for use in keratophakia procedures
EP3993746B1 (en) Corneal refractive correction using a surface treatment after corneal reshaping
WO1996029115A1 (en) Method for corneal laser surgery

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61F 9/01 A

Ipc: 7A 61F 9/08 B

Ipc: 7A 61B 3/107 B

17P Request for examination filed

Effective date: 20040130

AKX Designation fees paid

Designated state(s): DE ES FR GB IT

17Q First examination report despatched

Effective date: 20050523

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: 20/10 PERFECT VISION OPTISCHE GERAETE GMBH

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE ES FR GB IT

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60118311

Country of ref document: DE

Date of ref document: 20060518

Kind code of ref document: P

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2259651

Country of ref document: ES

Kind code of ref document: T3

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20070102

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20170829

Year of fee payment: 17

Ref country code: FR

Payment date: 20170823

Year of fee payment: 17

Ref country code: IT

Payment date: 20170913

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20170928

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20171004

Year of fee payment: 17

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60118311

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20180927

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190402

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180927

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180927

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20191104

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180928